Calendula officinalis Linn, known as pot marigold, is a plant that belongs to the Asteraceae family. Various online bibliographic databases namely, Google scholar, PubMed, SciFinder, and Web of Science were used for integrating information. Calendula officinalis is extensively used in Homoeopathic, Unani, and Ayurvedic system of medication as diaphoretic, analgesic, antiseptic, and anti-inflammatory agents and used to treat gynaecological issues, gastro-intestinal disorders, inflammations of oral and pharyangeal mucosa, eye problems, skin injuries and certain burns, poor eyesight, and menstrual irregularities. Several studies have shown that Calendula officinalis is a major source of diverse classes of bioactive compounds namely terpenoids, flavonoids, coumarines, quinones, and carotenoids. Various in vivo and in vitro assessment of Calendula officinalis's pharmacological activity suggest that the plant has antidiabetic, anti-inflammatory, anti-tumor, anticancer, and gastroprotective activity. This review compiles the information about pharmacological activities, traditional medicinal uses, and phytochemicals present in Calendula officinalis.
The plant Calendula officinalis Linn (C. officinalis) commonly called as pot marigold is a flowering plants belonging to Asteraceae family and Calenduleae tribe.1-3 The name calendula comes from the Latin word “calendas,” which means “first of the month.”4 The term marigold comes from calendula, which was formerly known as “gold's” and was connected to Queen Mary and the Virgin Mary.5C. officinalis is sessile, hispid, acute, oblanceolate, annual, or biennial herbaceous plant that is between 30 and 60 centimeters height. The leaves are hairy, alternating, petiolate, oblong, and spatulate, and have edges that are either whole or have few teeth. The lower leaves have rounded tips and oval shape while upper leaves are lance-shaped with pointed tips. The leaves blade length range from 2 to 4 inches.6 It has multiple secondary roots and possesses tap root with numerous secondary roots.7Figure 1 shows various parts of C. officinalis which includes flower, leaves and roots. The plant also contains essential oils which are produced from the flowers and the glandular hair present over the plant.8 The daisy like flowers are yellow to bright orange in color, curved, sickle-shaped, tubular and ringed achene, disc florets, and hermaphrodite.9,10
Different parts of C. officinalis.
The Calenduleae tribe has eight genera and more than 110 species, mostly found in South Africa.11 The plant is indigenous to Macaronesia East through Mediterranean region, Western Asia, United States, Europe, Cyprus, Turkey, Iran, and few other middle eastern countries as an ornamental plant.12 The larger scale cultivation is observed in India and China.13-15 Many gardeners think calendula can readily adapt to any climate and grow pleasantly since most soil types are good for its growth. It prefers a pH range of 6.0 to 7.5, wet, light sandy to clay, well-drained, poor to moderately rich soil, but will tolerate calcareous soil. In subtropical summer, plants will wither. Although seeds grow best in sunny spot and readily sprout out with well-drained soil.6,15,16
This study consolidates dispersed reports on the traditional applications, pharmacological properties, and phytochemistry of C. officinalis. However, our focus lies in highlighting the importance of C.officinalis as a natural therapeutic remedy, bolstered by positive findings in the literature. The aim of this review is to succinctly outline existing research, bridge any knowledge gaps, and present multiple avenues for researchers already exploring the validation of traditional claims and the safe, efficacious use of C. officinalis in treating diverse diseases.
Common Name
As indicated in Table 1, C. officinalis is frequently referred to by various names in different languages worldwide.
Common Name of CO in Various Languages.
S.N
Languages
Common name
1
English
Pot marigold, Scoth Marigold, Calendula, Marybud, Gold-bloom, Holligold, English Marigold
Ayurveda, Unani, Homeopathic, and other traditional system of medication utilize C. officinalis plant widely for curing different ailments. C. officinalis is a diaphoretic, analgesic, antiseptic, and anti-inflammatory agents and used to treat gynaecological issues, gastro-intestinal disorders, inflammations of oral and pharyangeal mucous, eye problems, skin injuries20 and certain burns,21 poor eyesight, and menstrual irregularities.8,22-24 It is also used as sudorific, blood refiner, and blood sugar reducer.25 The flower's head has been utilized as tinctures, balms, and salves for its cicatrizing, anti-tumor,26 blood refiner, peptic-ulcer, astringent, diuretic, hypoglycemic, and antipyretic properties.27-30 In India, Calendula ointments are applied topically to treat skin damage, gangrene, wounds,31 acne, chicken pox, mumps, scars, herpes, ulcers, frostbite, and wounds.32 Insect bites, carbuncles, varicosities, dermatitis, boils, and oral sores or tooth ache can all be treated with its infusion.33 For the treatment of varicose veins, leaves are placed externally in fusion form. Calendula drinks are used as gargles, eye washes and treatments for inflammatory disorders of the mucous membranes as well as for diaper rashes, hemorrhoids, stomatitis, and conjunctivitis.34,35 Besides its use in human, it has been extensively used in veterinary homeopathy as well.36
Chemical Constituents
The entire C. officinalis plant is a rich source of many phytochemical components, with varying amounts and qualities of these components in different plant sections. The most prevalent ones are terpenoids, flavonoids, saponins, sterols, phenolic acids, coumarins, quinines, amino acids, essential oil, and carotenoids as shown in Table 2.34,37-40
List of Phytochemicals Present in Calendula officinalis.
The therapeutic effects of the C. officinalis is caused by a significant group of secondary metabolites called terpenoids.1,8,41 Various terpenoids isolated (Figure 2) are calenduladiol-3-O-palmitate, stigmasterol, lupeol, Ψ-taraxasteol,42 calenduladiol-3-O-myristate, arnidiol-3-O-myristate, arnidiol-3-O-laurate, arnidiol-3-O-palmitate, faradiol-3-O-laurate, faradiol-3-O-palmitate, faradiol-3-O-myristate,8,43 calendulosides A–H,8,37,44 and calendulaglycoside A and B.27,45
Chemical structure of terpenoids specific for C. officinalis.14,37,38,44.
Flavonoids
Flavonoids are mostly present in flowers of C. officinalis. Some of the isolated flavonoids (Figure 3)14,37 are quercetin, calendoflaside, calendoflavoside, isoquercetin, calendoflavobioside, rutin, gallic acid,46 isorhamnetin,47 isorhamnetin-3-O-D-glycoside, narcissin,48 pinobanksin 3-acetate,49 isorhamnetin-3-O-D-glycoside, neohesperidoside, isorhamnetin-3-O-2G-rhamnosyl rutinoside, quercetin-3-O-glucoside, isorhamnetin-3-O-2G quercetin, scopoletin-7-O-glucoside, isorhamnetin-3-O-glucoside calendoflavobioside, isorhamnetin-3-O-2G-rhamnosyl rutinoside, and isorhamnetin-3-O-2G.50-54
Chemical structure of flavonoids specific for C. officinalis.14,37.
Coumarins
The extract of C. officinalis contains (Figure 4)—umbelliferone, scopoletin, and esculetin.55,56 The other coumarins glyscoside isolated are isobaisseoside, haploperoside A, and haploperoside D. A new coumarin glycoside, and neoisobaisseoside are present on its flowers.57,58
Chemical structure of coumarines specific for C. officinalis.37.
Sterols
The leaves of C. officinalis are the major source of sterols. Campesterol, sitosterol, cholestanol, campestanol, stigmastanol, 24-methylcholest-7-en-3β-ol, stigmast-7-en-3β-ol, cholesterol, cholest-7-en-3-β-ol, umbelliferon, aesculetin,36 24-methylcholesta-5,22-dien-3β-ol, 24-methylenecholesterol, stigmasterol, and clerosterol (Figure 5) were isolated from leaves.59-62
Chemical structure of sterols specific for C. officinalis.57.
Quinones
Phylloquinone, tocopherol, and plastoquinone are present in chloroplast and ubiquinone, and phylloquinone (Figure 6) are found in the leaves.63
Chemical structure of quinones specific for C. officinalis.37.
Essential Oil
The essential oils are predominately isolated from flowers of C. officinalis. The highest (0.97%) content of essential oils are present during the full blooming stage while lowest (0.13%) during pre-flowering stage.64 The essential oil contains (Figure 7) calendic acid, 1,8-Cineol, p-cymene, trans—ocimene, thujene, α-pienene, sabinene, limonene, α-terpenene, Nonanal, terpene-4-ol, 6-Methyl-5-heptene-2-one, 2-Pentylfuran, benzeneacetaldehyde, γ-terpinene, 4-methylbenzaldehyde, terpinolene, linalool, 2,6-dimethylcyclohexanol, cis-p-mentha-2-en-1-ol, epi-α-muurolol, α-cadinol, terpinen-4-ol, α-terpineol, safranal, n-decanal, β-cyclocitral, carvone, dihydrojasmone, p-thymol, α-cubebene, α-Ionone, γ-muurolene, γ-cadinene, palmitic acid, δ-cadinene, τ-muurolol, selina-6-en-4-ol, β-ionone, δ-cadinol, τ-cadinol, β-oplopenone, α-cadinol, calamemene, viridiflorol, 1-epi-cubenol, and cadalene.65-69
Chemical structure of essential oil component specific for C. officinalis.57.
Carotenoids
The yellow-orange hue of flowers is attributed to the vast amounts of carotenoids (Figure 8) found in C. officinalis inflorescences; the exact shade of color is determined by the pigment profile and content. In petal extracts of C. officinalis cultivars with orange and yellow flowers, 19 carotenoids were found. Cultivars with orange flowers were specific to 10 carotenoids.67,70
Chemical structure of carotenoids specific for C. officinalis.57,69.
Bakó et al examined carotenoids content and discovered roughly eighteen distinct kinds of carotenoids: Neoxanthin, 9´Z-auroxanthin, luteoxanthin, and neoxanthin (9´Z)-violaxanthin, mutatoxanthin, α and β-carotene, flavoxanthin, violaxanthin and 9´Z-lutein, astaxanthin, and 9/9´Z-lutein (13/13´Z)-lutein.71
Nineteen distinct carotenoids, including flavoxanthin, lutein-5,6-epoxide, (8´R)-luteoxanthin, and (8R/8´R)-lutein, were discovered by Kishimoto et al (2005)—auroxanthin, lutein, antheraxanthin, (9Z)-lutein-5,6-epoxide, (9Z)-lutein, (5´Z/9´Z)-rubixanthin, α-, β-, and (5´Z)-carotene, δ-carotene, (5Z/9Z/5´Z/9´Z)-lycopene, γ-carotene, and (5´Z)-γ-carotene, (5Z/9Z/5Z)-lycopene, (5Z/9Z)-lycopene, and all-alycopene. (5´Z)-γ-carotene and (5´Z/9´Z)-rubixanthin are two of their carotenoid.67,72 13Z-violaxanthin, lutein, 9/92-lutein, antheraxanthin, and mutatoxanthin epimer 1 were all found in the petals.71
Amino Acids
It is stated that 15 amino acids are present in the flower extracts in free form: leucine, valine, proline, histidine, asparagines, glutamic acid, lysine, serine, threonine, methionine, alanine, arginine, aspartic acid, tyrosine, and phenylalanine.26,73,74
Carbohydrates
Carbohydrates like polysaccharides, I, II, and III are present.75 There are also other monosaccharides such as glucose, xylose, galactose, rhamnose, arabinose, and galacturonic acid.76
Lipid and Fatty Acids
C. officinalis seeds contain neutral lipids, glycolipids, and phospholipids among other lipids. Among the identified lipids in C. officinalis are (Figure 9) palmitic acid, myristic acid, lauric acid, stearic acid, limoleic acid, oleic acid, D-(+)-9-hydroxy-10,12-octadecadienoic acid, and linolenic acid.73,77
Chemical structure of lipid and fatty acids specific for C. officinalis.57.
The 11 genotypes of oils produced from calendula seeds contained nineteen fatty acids. Calendic acid and linoleic acid (51.47%-57.63% and 28.5-31.9%) were discovered to be the most prevalent fatty acids, followed by oleic acid (4.44-6.25%) and palmitic acid (3.86-4.55%).78,79
Pharmacological Activities
C. officinalis is frequently used in cure of numerous illnesses. It may also be cytotoxic and stop the growth of tumors. It has been used for medicinal properties as an antibacterial, antioxidant, anti-inflammatory, antiseptic, antiviral, hepatoprotective, gastro-intestinal issues, obstetric issues, anti-mutagenic, and antidiabetic as shown in Figure 10.80-82
Pharmacological action of C.officinalis.
Antidiabetic Activity
Diabetes is a significant global health concern due to its rapid global expansion. Although diabetes mellitus (DM) is common worldwide, more industrialized nations have higher rates of the disease, particularly Type 2. DM ranks among the top 10 causes of death worldwide, ranking alongside respiratory, cardiovascular, and cancer disorders. According to reports, people with diabetes between the ages of 20 and 99 caused almost 5 million deaths globally in 2017.83 Therefore, it has always been desirable to identify new antidiabetic medications composed of natural plants because some of their constituents have been shown to be safe and effective alternatives to conventional medications for DM.84 Many researchers have reported the antidiabetic activity of C. officinalis.
In vivo models using diabetic rats generated by streptozotocin (STZ) and diabetic rats induced by alloxan were used to analyze the antidiabetic activity of C. officinalis extracts. Additionally, in vitro assays, such as amylase inhibitory activity and α-glucosidase inhibition, were conducted to further evaluate the extracts’ potential impact on diabetes. Chakraborthy et al examined the antidiabetic properties of a hydroalcoholic extract of C. officinalis in alloxan-induced diabetic rat models. The extract, prepared with a 70:30 alcohol to water ratio using the soxhlet extraction method, was orally administered at 100 mg/kg body weight. This led to reductions in serum lipid levels, urine sugar, and blood glucose in diabetic rats.85 Additionally, in male rats with STZ-induced diabetes, treatment with C. officinalis resulted in significant increases in insulin, glutathione, and serum inflammatory cytokines (tumor necrosis factor (TNF)-1 and interleukins-1 (IL-1)), alongside decreases in malondialdehyde and glucose levels at doses of 200 and 400 mg/kg.86 Moradkhani et al found a substantial reduction in plasma glucose levels in STZ-induced diabetic rats treated with a hydroalcoholic plant extract at 300 mg/kg.87 In a similar manner, the hydroalcoholic extract of flowers (250 and 500 mg/kg) was assessed using a model of diabetic rats induced by STZ. The research revealed a noteworthy reduction in fasting blood sugar (P < 0.05).88 In another study, rats with alloxan-induced diabetes had lower blood glucose levels when exposed to a plant 100 mg/kg of hydroacholic extract.85 Additionally, the plant extracts aid to lessen oxidative stress, fluctuating creatine kinase levels, weight loss, and other abnormalities in diabetic rats.89
Neoisobaisseoside a glycoside was isolated from C. officinalis and was found inhibiting α- amylase and α- glucosidase enzyme significantly which support the antidiabetic property of C. officinalis.57 A C. officinalis leaf ethyl acetate and ethanolic extract-soluble fraction demonstrated a noteworthy reduction in amylase activity. Significant and strong inhibitory effects on amylase were demonstrated by isoquercitrin, 3,5-di-O-caffeoylquinic acid, isorhamnetin-3-O-β-D-glucopyranoside, and quercetin-3-O-(6′′-acetyl)-β-D-glucopyranoside.90 Thus, the presence of different flavonoids, glycosides, moderate amounts of alkaloids steroids and saponins which possess higher antioxidant activity may be the reason for exhibiting significant antidiabetic activity.27,91
Antioxidant Effects
The existence of free radicals, whether generated outside or internally by the body, has been linked to diseases such as liver cirrhosis, atherosclerosis, inflammation, diabetes, neurological illnesses, and cancer. This connection between free radicals and these diseases has spurred extensive research into safe medications capable of neutralizing these radicals. Numerous studies have highlighted the considerable antioxidant capabilities of various plant extracts and plant-based products in this regard.92,93
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging activity, nitric oxide (NO) radical scavenging, ferric reducing antioxidant power (FRAP), superoxide radical scavenging, and in vivo procedures are the primary methods used to assess the antioxidant activity of the C. officinalis plant.
C. officinalis flower extract efficiently scavenged superoxide radicals (inhibitory concentration 50 (IC50) = 500 µg/mL), hydroxyl radicals (IC50 = 480 µg/mL), and lipid peroxidation (IC50 = 2000 µg/mL). It also demonstrated scavenging activity against DPPH radicals (IC50 = 100 µg/mL) and ABTS radicals (IC50 = 6.5 µg/mL). Moreover, the extract exhibited dose-dependent scavenging of NO in culture (IC50 = 575 µg/mL). In vivo administration of oral calendula extract reduced macrophage superoxide production by 12.6% and 38.7% at dosages of 100 and 250 mg/kg body weight, respectively. Additionally, after 1 month of treatment, higher levels of glutathione and catalase were observed in the liver and blood, along with modifications in glutathione reductase and peroxidase.94 Using FRAP and DPPH radical scavenging techniques, the antioxidant capacity of the ethanolic extract of C. officinalis was evaluated. The presence of flavonoids, saponins, and polyphenols—all recognized for their antioxidant qualities—was verified by a preliminary phytochemical investigation. It was found that the IC50 for radical scavenging activity was 116 µg/mL.95 Through its ability to scavenge NO radicals, DPPH, and ABTS, flower extract of C. officinalis has demonstrated notable antioxidant activity. Using the FRAP method, the mouthwash made from C. officinalis was also assessed for its antioxidant activity and showed a decreased IC50 value that was comparable to ascorbic acid.94,96 Moreover, the FRAP method was used to assess the antioxidant activity of C. officinalis floral extract with varying proportions of water and ethyl alcohol. The hydro alcoholic extract (50:50 v/v) exhibited the highest level of antioxidant activity.
In a different investigation, the antioxidant activity of silver nano-particles biosynthesized from C. officinalis aqueous extract was assessed using the DPPH, FRAP, and ABTS methods. Using the ABTS technique, the study's strongest antioxidant activity was discovered. The values of antioxidant activity ranged from 14.3 to 43.6 mg CGA g−1 DW.97 In a related investigation, high-performance liquid chromatography was used to assess and quantify the antioxidant activity of C. officinalis hydroalcoholic leaf extracts. The DPPH technique for superoxide and hydroxyl radicals was used to evaluate antioxidant capability. The plant's significant antioxidant activity was demonstrated by the DPPH and hydroxyl methods in particular. This activity may have been caused by the plant's identification of flavonoids (24.67 mg/g), polyphenols (33.90 mg/g), condensed tannins (27.30 mg/g), rutin (37.25 mg/g), and quercetin (6.09 mg/g) in the study.98 Using DPPH free radical, hydroxyl radical, and lipid peroxyl radical as indicators of effects, Cetkovic et al investigated the effects of methanolic and water extracts from growing wild marigold (GWM), Calendula arvensis L., and cultivated marigold at concentrations ranging from 0.10 to 0.90 mg/ml. Cultivated marigold extracts demonstrated stronger antioxidant and scavenging activity than GWM extracts; water extracts performed better than methanolic extracts. The most potent antioxidants were found in the water extracts from cultivated marigold; at a concentration of 0.75 mg/ml, they totally removed the hydroxyl radicals produced in the Fenton system. This extract prevented 92% of DPPH radicals and 95% of peroxyl radicals from forming during lipid peroxidation at the same dose.24 The substantial concentration of polyphenols, flavonoids, and tannins in the plant extract may be the cause of its high antioxidant potential.99
Anti-inflammatory and Analgesic Activity
For many years, C. officinalis has been a mainstay in conventional medicine, used to treat both human and animal pain and inflammation. This adaptable treatment is made in many forms—tinctures, ointments, lotions, decoctions, and fluid extracts—for a range of uses. The plant's flowers and leaves can be used to make galenic medicines and pharmaceutical formulations that have a variety of pharmacological effects, most notably analgesic and anti-inflammatory properties.100
An animal study verified calendula flower extract's ability to effectively reduce inflammation. NO, a pro-inflammatory substance produced by NO synthase and strongly secreted by innate immune cells during inflammation, is influenced by flower extract of C. officinalis. Calendula flower extract was discovered to display a dose-dependent suppression of NO, with a 50% decrease at 147 μL/mL without resulting in any harm to cells. This offers significant proof of the anti-inflammatory characteristics of calendula flower extract.101 An assessment was made of the analgesic and anti-inflammatory qualities of a hydroalcoholic extract derived from the aerial section of Pot marigold. Acetic acid writhing tests and hot water tail immersion were utilized to assess its analgesic effects. Additionally, paw edema generated by carrageenan was used to test the ability to prevent inflammation. For the trials, adult male and female Wistar rats weighing 200–220 g and albino mice weighing 20–30 g were employed. Additionally, the extracts showed a dose-dependent effect on the suppression of inflammation and discomfort.102 Using albumin denaturation assays, the anti-inflammatory properties of the C. officinalis tea formulation were assessed. At 10 µl and 20 µl, the extract showed a substantial anti-inflammatory effect (P-values of 0.002 and 0.000, respectively). It was discovered that the anti-inflammatory activity outperformed the control group at every concentration tested.103 In another investigation, the anti-inflammatory efficacy of C. officinalis extracts was assessed using the carrageenan-induced acute paw edema and dextran-induced acute paw edema methods. In both approaches, the oral administration of floral extract (250 and 500 mg/kg) resulted in a considerable suppression of rat paw edema. Its anti-inflammatory effect is supported by the observation that pro-inflammatory cytokines such as IL-1beta, IL-6, TNF-alpha, and IFN-gamma, as well as acute phase protein, C-reactive protein, were decreased in mice.104
C. officinalis floral oils were tested for their ability to reduce inflammation in response to LPS-stimulated macrophages. The outcome demonstrates that calendula oil (147 µL/mL) dramatically (50%) decreased nitrite formation, and the presence of other terpenoids, such as faradiol, is crucial for demonstrating anti-inflammatory effect.101,105 The plant's extract from the leaves has analgesic properties as well. The analgesic efficacy of pure and diluted C. officinalis leaf extract (1:1, 1:2) was studied in mice following intraperitoneal injection. The pure extract exhibited the highest degree of analgesic effectiveness and the longest duration of action after thirty minutes of injection.106
Antibacterial Activity and Antifungal Activity
Numerous investigations were carried out to assess the antifungal and antibacterial properties of C. officinalis. Using the agar well diffusion method, it was discovered that C. officinalis floral oil demonstrated strong antibacterial action against Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.107 The antibacterial activity of CO tincture 60% (v/v) was found significant against Pseudomonas aeruginosa by disc diffusion method.108 The leaf powder of C. officinalis showed significant antibacterial activity in agar well diffusion method against Bacillus subtulis, Staphylococcus aureus, Escherichia coli, Candida glabrata, and Klebsiella pneumonia.109-112 Similarly Ghaima et al conducted antibacterial assay of water extract of C. officinalis flower against Salmonella, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, and E. coli by agar diffusion method in which the adherent growth of bacteria's were decreased.112 A study was conducted which compare the antimicrobial property of the mouth wash that contain C. officinalis L., Camellia sinensis (L.) Kuntze extract, and 0.12% chlorhexidine digluconate. It was found that all mouth wash exhibited antimicrobial property but they were not effective as 0.12% chlorhexidine digluconate. The antibacterial activity of C. officinalis was supposed to be exhibited by the presence of oleanolic acid,113 alkaloids, glycosides, flavonoids, and terpenoids.112
The antifungal activity of C. officinalis was evaluated against A.niger, R. japonicum, Candida krusei, Candida tropicallis, Candida parapsilosis, Candida dubliniensis, Candida albicans, Candida glabrata, and R.glutinis fungus. The growth inhibition ranged from 10 mm to 20 mm against those tested fungi and was comparable to amphotericin B and nystatin. The antifungal activity of C. officinalis may be due to the presence of phytochemicals like cardiac glycoside, sterols, and flavonoids.23,114
Anticancer Activity
The crystal violet assay and 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay are some of the methods to evaluate anticancer activity of C. officinalis plants. The methanolic leaves extract was evaluated by crystal violet assay against Michigan Cancer Foundation-7 (MCF-7), Ahmed, Mahfoodha, Mortadha, Jabria-2013 (AMJ13), M.D. Anderson-metastasis breast cancer (MDA-MB), and CAL51 breast cancer lines. The growth of cancer cell was inhibited by extract lines while significant inhibition was found in MDA-MB cells.115 The anti-colorectal cancer activity of silver nano-particles of C.officinalis was evaluated against MTT assays which decreased the colorectal cell lines.4 The cytotoxic activity of some isolated compounds like lutein, lupeol, and eugenols were evaluated by MTT assays against breast cancer cell lines (MCF-7 and MDA-MB-231) and normal breast cell line (MCF 10A). The messenger ribonucleic acid (mRNA) expression level of p53, caspase-3, and bax genes were measured which were found to increase in both cancer cells, and B-cell lymphoma 2 (Bcl-2) gene expression deduced in treated breast cancer cells.116 The presence of major flavonoids which are flavone and luteolin-7-O-β-glucoside which is used in cancer therapy are present in C. officinalis and may be useful for exhibiting anticancer activity.117
Cardio-protective Effect
C. officinalis extracts are found to be effective against ischemic heart disease. By altering antioxidant and anti-inflammatory pathways, cardio-protective activity is done by turning the ischemia reperfusion-mediated death signal into a survival signal, as shown by the activation of protein kinase B (Akt) and Bcl2 and the reduction of TNF-α.118 In another study, plant extract (0.3 mg/l) inhibited the heart rate contractility by 100% which may be due to spasmogenic activity of plant extract.34,119
Antiulcer Activity
Pyloric ligation-induced ulcer model, ethanol-induced ulcer model, cold-resistant ulcer and indomethacin-induced ulcer model were widely used models to assess antiulcer activity of C. officinalis. C. officinalis ethanolic extract decreased the gastric acid effects on mucosa as compared to ranitidine in experimental rats.120 The hydroalcoholic extract was found effective in reducing the gastric acid secretion and prevent the effects of aspirin in gastric mucosa.121 Yadav et al investigated the antiulcer efficacy of C. officinalis entire plants (250 and 450 mg/kg/b.w) and discovered that the maximum treatment efficiency (450 mg/kg b.w.) in cold-resistant stress-induced ulcers was 87.15%. This was shown to be suppressing the formation of ulcers generated by physical and chemical agents.122
The pharmacological properties of some isolated compounds are as shown in Table 3.
List of Isolated Compounds and its Pharmacological Action.
Rats and mice were given the hydroalcohol extract (HAE) made from C. officinalis to evaluate its acute toxicity through oral administration. Its subacute effects on biochemical, morphologic, and hematological markers in rats were also assessed. The rats in the acute toxicity test did not die when oral dosages of HAE up to 5.0 g/kg were given. In comparison to the control group, oral administration of HAE at doses of 0.025, 0.25, 0.5, and 1.0 g/kg did not result in any appreciable hematological alterations. However, elevated levels of alanine transaminase (ALT) and blood urea nitrogen were noted in terms of biochemical markers. Examinations of the brain, kidney, and heart morphologically showed no obvious changes.131 Male and female Wistar rats were used to test the acute and sub-chronic oral toxicities of C. officinalis extract. Sub-chronic doses of 50, 250, and 1000 mg/kg/day were given in drinking water, whereas a single acute dose of 2000 mg/kg dissolved in distilled water was given orally. Numerous toxicological endpoints were assessed, such as body weight, food and water consumption, tissue weights, and results of histological analyses. Blood chemistry (glucose, cholesterol, urea, proteins, ALT, aspartate aminotransferase (AST), alkaline phosphatase) and blood elements (hematocrit, hemoglobin, erythrocyte and leukocyte count, clotting time) were also examined. There were no deaths or toxicity indicators in the acute investigation. Nonetheless, several blood components—hemoglobin, erythrocytes, leukocytes, and clotting time—were substantially impacted in both genders in the sub-chronic trial conducted 90 days later. There was also an effect on blood chemistry measures such as alkaline phosphatase, AST, and ALT. Histopathological analysis identified little irregularities in the liver tissue that matched the biochemical changes that had been seen. These results collectively imply that there are less acute and sub-chronic toxicity associated with.132,133
Using organization for economic co-operation and development (OECD) criteria 402 and 411, another study was carried out to examine the acute and sub-chronic skin toxicity of calendula essential oil in order to determine its safety. Animals exposed sub-chronically to C. officinalis essential oil for 90 days were given doses of 2.5, 5, and 10 mL/kg, while animals exposed acutely to 20 mL/kg of the oil. The CNS effects, organ weight, necropsy, biochemical and hematological variables, and histopathology were among the parameters. Every animal exhibited typical behavior, and there were no anomalies found in the necropsy, histology, blood biochemistry, or hematology. It was discovered that the CO oil's no observed adverse effect level and no observed effect level were 2.5 and 10 mg/kg/day, respectively. With an LD50 value of 20 mL/kg body weight, C. officinalis oil categorized by the European Medicines Agency as a herbal medical product showed no appreciable harmful effects.134
Industrial and Pharmaceutical Applications
C. officinalis extract is a botanical ingredient extensively utilized in cosmetics for its soothing and skin-conditioning attributes. It is a key component in various products such as creams, balms, and serums, offering gentle and natural skincare solutions. Commonly known as calendula oil, this extract provides numerous benefits, nurturing the skin and enhancing overall complexion.135 The market for C. officinalis flower extract witnessed significant growth, reaching USD 26 billion in 2023. Projections indicate further expansion, with an expected value of USD 64.43 billion by 2030, fueled by a compound annual growth rate) of 30% from 2024 to 2030.136C. officinalis preparations commonly include carophyllenic ointment, which contains carotenoids extracted from the flowers, as well as pot marigold tincture. Additionally, it serves as a component in proprietary homeopathic medicines, utilized for addressing symptoms linked with acute musculoskeletal injuries such as pain and swelling.137 Furthermore, otic solution and naturopathic herbal extract ear drops, formulations derived from naturopathic principles containing Calendula flowers, have demonstrated efficacy in managing otalgia associated with acute otitis media in children.8,138
Furthermore, the exploration of novel drug delivery systems incorporating C. officinalis extract is still in its early stages, with on-going research anticipated in this domain. Molecular docking and molecular dynamics represent modern computational techniques in drug design, holding significant promise for the development of new therapeutic candidates across various health conditions. By analyzing the chemical composition of medications and their target receptors, the therapeutic potential of numerous bioactive compounds can be investigated, offering potential savings in time and resources. In the foreseeable future, formulations containing C. officinalis at micro- and nano-levels demonstrate promising prospects for treating various ailments, with anticipated advancements and applications expected to be remarkable. Additionally, combining C. officinalis with other available agents for activity enhancement presents a promising strategy that could ultimately improve pharmacological outcomes.139
Conclusions
C. officinalis is one of the most potent and beneficial flowering plant with multi health benefits and pharmacological actions. It contains different chemical constituents like: terpenoids, glycosides, flavonoids, volatile oil, and carbohydrates that results different physiological actions in the body. Various clinical studies have also proven the useful therapeutic activities like: antioxidant, antidiabetic, hypolipidemic, anti-inflammatory, hepatoprotective, and anticancer. These all activities make the plant rich in bioactivities and even depict the remarkable possibilities of the plant in the field of research and medicine. Numerous studies have been performed and showed the flowers extract contained the greater biological activities in comparison to the other parts. Furthermore, comprehensive study in relation to the safety and efficacy as well as toxicity should be performed for the proper designing of the formulations of the plant in the future.
Footnotes
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
ORCID iDs
Biswash Sapkota
Paridhi Kunwar
References
1.
MuleyBPKhadabadiSSBanaraseNB. Phytochemical constituents and pharmacological activities of Calendula officinalis Linn (Asteraceae): a review. Trop J Pharm Res. 2009;8(5):455-465.
2.
ShahaneKKshirsagarMTambeS, et al.An updated review on the multifaceted therapeutic potential of Calendula officinalis L. Pharmaceuticals. 2023;16(4):1-21.
3.
FishbeinM. Plant systematics: a phylogenetic approach. Third Edition.Q Rev Biol. 2008;83(3).
4.
XuYMahdaviBZangenehMZangenehAQorbaniMPaydarfardS. Calendula officinalis green-mediated silver nanoparticles: formulation, characterization and assessment of colorectal cancer activities green-mediated silver nanoparticles. Arch Med Sci. 2021:1-9.
5.
GrieveM. A modern herbal: the medicinal, culinary, cosmetic, and economic properties, cultivation, and folklore of herbs, grasses, fungi, shrubs, and trees with all their modern scientific uses. Jonathan Cape Ltd; 1992:456 p.
KadowakiWMiyataRMizunoSFujinamiMSatoYKumazawaS. Prenylated acetophenones from the roots of Calendula officinalis and their anti-inflammatory activity. Biosci Biotechnol Biochem. 2023;87(7):683-687.
8.
AroraDRaniASharmaA. A review on phytochemistry and ethnopharmacological aspects of genus Calendula. Pharmacogn Rev. 2013;7(14):179-187.
9.
JohnRJanN. Calendula officinalis-an important medicinal plant with potential biological properties. Proc Indian Natl Sci Acad. 2017;93(0):769-787.
10.
GlombitzaKW. Herbal Drugs and Phytopharmaceuticals. A handbook for practice on a scientific basis. Von Norman Grainger Bisset (Ed.), und Max Wichtl. medpharm Scientific Publ., Stuttgart; CRC Press 1994, Boca Raton etc.; 566 Seiten, 434 farbige, 312 schwarzweiße Abbild. Pharm Unserer Zeit. 1995.
11.
MallickPK. Karyomorphology, meiotic behaviours and pollen fertility of Calendula officinalis L. (Calenduleae- Asteraceae). Int J Appl Sci Biotechnol. 2021;9(1):75-79.
12.
BaschEBentSFoppaI, et al.Marigold (Calendula officinalis L.): an evidence-based systematic review by the natural standard research collaboration. J Herb Pharmacother.2006;6(3):135-159.
13.
ErcetinTSenolFSErdogan OrhanITokerG. Comparative assessment of antioxidant and cholinesterase inhibitory properties of the marigold extracts from Calendula arvensis L. and Calendula officinalis L. Ind Crops Prod. 2012;36(1):203-208.
14.
SzopaAKlimek-SzczykutowiczMJafernikKKocKEkiertH. Pot marigold (Calendula officinalis L.) – A position in classical phytotherapy and newly documented activities. Acta Sci Pol Hortorum Cultus. 2020;19(3):47-61.
15.
AshwlayanVDKumarAVermaMGargVKGuptaS. Therapeutic potential of Calendula officinalis. Pharm Pharmacol Int J. 2018;6(2):149-155.
16.
CromackHTHSmithJM. Calendula officinalis—production potential and crop agronomy in Southern England. Ind Crops Prod. 1998;7(2–3):223-229.
17.
KrikorianAD. A Modern Herbal. The medicinal, culinary, cosmetic and economic properties, cultivation and folk-lore of herbs, grasses, fungi, shrubs & trees, with all their modern scientific uses; with a new service index. Volumes I and II. M. Grieve, C. F. Leyel. Q Rev Biol. 1968;43(4):461-461.
18.
KarteszJ. A synonymized checklist of the vascular flora of the United States, Canada, and Greenland. In: a synonymized checklist of the vascular flora of the United States, Canada, and Greenland. 2nd ed. Timber, Press; 1994:2.
19.
AajM. Phytochemistry and Pleiotropic Pharmacological Properties of Calendula Phytochemistry and Pleiotropic Pharmacological Properties of Calendula. 2014;(October).
20.
AkhtarNZamanSUKhanBAAmirMNEbrahimzadehMA. Calendula extract: effects on mechanical parameters of human skin. Acta Pol Pharm - Drug Res. 2011;68(5):693-701.
21.
SinghMKSahuPNagoriK, et al.Organoleptic properties in-vitro and in-vivo pharmacological activities of Calendula officinalis Linn: an over review. J Chem Pharm Res.2011;3:655-663.
22.
SindhuCG. Phytochemical screening of Calendula officinalis Linn leaf extract by Tlc. Int J Res Ayurveda Pharm. 2010;1(1):131-134.
23.
KasiramKSakharkarPRPatilAT. Antifungal activity of Calendula officinalis. Indian J Pharm Sci. 2000;62(6):464-466.
24.
ĆetkovićGSDjilasSMČanadanović-BrunetJMTumbasVT. Antioxidant properties of marigold extracts. Food Res Int. 2004;37(7):643-650.
25.
MohammadSM. Pot marigold (Calendula officinalis) medicinal usage and cultivation. Sci Res Essays. 2012;7(14):1468-1472.
26.
PatilKSanjayCDoggalliNDeviKRHarshithaN. A review of Calendula officinalis magic in science. J Clin Diagnostic Res. 2022;16(2):23-27.
27.
UkiyaMAkihisaTYasukawaKTokudaHSuzukiTKimuraY. Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers. J Nat Prod. 2006;69(12):1692-1696.
28.
SafdarWMajeedHNaveedI, et al.Pharmacognostical study of the medicinal plant Calendula officinalis L. (Family Compositae). Int J cell Mol Biol. 2010;1(2):108-116.
29.
RajwinderKRajmeetSJaswinderK. Phytochemical composition and biological activities of Calendula officinalis L.: a review. Int J Pharm Res Innov. 2020;13:34-37.
30.
ChaparzadehND’AmicoMLKhavari-NejadRAIzzoRNavari-IzzoF. Antioxidative responses of Calendula officinalis under salinity conditions. Plant Physiol Biochem. 2004;42(9):695-701.
31.
GivolOKornhaberRVisentinDClearyMHaikJHaratsM. A systematic review of Calendula officinalis extract for wound healing. Wound Repair Regen.2019;27(5):548-561.
32.
DekaBBhattacharjeeBShakyaAIkbalAMAGoswamiCSarmaS. Mechanism of action of wound healing activity of Calendula officinalis: a comprehensive review. Pharm Biosci J. 2021;9(1):28-44.
33.
DhingraGDhakadPTanwarS. Review on phytochemical constituents and pharmacological activities of plant Calendula officinalis Linn. Biol Sci. 2022;02(02):216-228.
34.
VermaPKRainaRAgarwalSKourH. Phytochemical ingredients and pharmacological potential of Calendula officinalis Linn. Pharm Biomed Res.2018;4(2):1–17.
35.
BokelmannJM. Calendula (Calendula officinalis). Med Herbs Prim Care. 2022;6(3):263-267.
36.
Calendula officinalis (use in Veterinary homeopathy). The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit. 1998.
37.
MuleyBPKhadabadiSSBanaraseNB. Phytochemical constituents and pharmacological activities of Calendula officinalis Linn (Asteraceae): a review. Trop J Pharm Res. 2009;8(5):455-465.
38.
BelalAElananyMARaafatMHamzaHTMehanyABM. Calendula officinalis phytochemicals for the treatment of wounds through matrix Metalloproteinases-8 and 9 (MMP-8 and MMP-9). In Silico Approach. Nat Prod Commun. 2022;17(5):1934578X221098848.
39.
BraunLCohenM. Herbs and natural supplements: an evidence-based guide. 3rd ed. 2010:31.
40.
JodhRTawarMBehereSRandhaveNJirapurePIngleS. A review on Calendula officinalis. Res J Pharmacogn Phytochem. 2023;15(1):5-10.
41.
AuguścińskaEKasprzykZ. Studies on the labelling of terpenoids in shoots and cells or protoplasts from Calendula officinalis leaves. Acta Biochim Pol. 1982;29(1-2):7-15.
42.
KadhimNAAl-AniWMKAl-JobouryIS. Detection of lupeol in Calendula Officinalis grown in Iraq by GC-MS analysis. Al Mustansiriyah J Pharm Sci. 2019;19(4):69-76.
43.
Zitterl-EglseerKSosaSJurenitschJ, et al.Anti-oedematous activities of the main triterpendiol esters of marigold (Calendula officinalis L.). J Ethnopharmacol. 1997;57(2):139-144.
44.
VecherkoLPZinkevichEPLibizovNIBan’kovskiiAI. The structure of calenduloside A. Chem Nat Compd. 1971;7(1).
45.
NeukirchHD’AmbrosioMSosaSAltinierGDella LoggiaRGuerrieroA. Improved anti-inflammatory activity of three new terpenoids derived, by systematic chemical modifications, from the abundant triterpenes of the flowery plant Calendula officinalis. Chem Biodivers. 2005;2(5):657-671.
46.
KomissarenkoNFChernobaiVTDerkachAI. Flavonoids of inflorescences of Calendula officinalis. Chem Nat Compd. 1989;24(6):675-680.
47.
OlennikovDNKashchenkoNIChirikovaNKAkobirshoevaAZilfikarovINVennosC. Isorhamnetin and quercetin derivatives as anti-acetylcholinesterase principles of marigold (Calendula officinalis) flowers and preparations. Int J Mol Sci. 2017;18(8):1685.
48.
HamadMN. Detection and isolation of flavonoids from Calendula officinalis (F.Asteraceae) cultivated in Iraq. Iraqi J Pharm Sci. (P-ISSN 1683 - 3597 E-ISSN 2521 - 3512). 2016:1-6.
49.
Al-HuqailAABekhitAAUllahHAyazMMostafaNM. Antimalarial and antileishmanial flavonoids from Calendula officinalis flowers. Agronomy. 2023;13(11):2765.
50.
RaalAKirsipuuK. Total flavonoid content in varieties of Calendula officinalis L. originating from different countries and cultivated in Estonia. Nat Prod Res. 2011;25(6):658-662.
51.
RiganeGBen YounesSGhazghaziHBen SalemR. Investigation into the biological activities and chemical composition of Calendula officinalis L. growing in Tunisia. Int Food Res J. 2013;20(6):3001.
52.
OkohOOSadimenkoAAAfolayanAJ. The effects of age on the yield and composition of the essential oils of Calendula officinalis. J Appl Sci.2007;7:3806-3810.
53.
Santosh FerreiraCDPereyraAPatriarcaA, et al.Phenolic compounds in extracts from Eucalyptus globulus leaves and Calendula officinalis flowers. J Natural Prod Resources. 2016;2(1):53-57.
54.
KurkinVASharovaOV. Flavonoids from Calendula officinalis flowers. Chem Nat Compd. 2007;43(2):216.
55.
DerkachAIKomissarenkoNFChernobaiVT. Coumarins of the inflorescences of Calendula officinalis andHelichrysum arenarium. Chem Nat Compd. 1986;22:722-723.
56.
JohnRJanN. Calendula officinalis-an important medicinal plant with potential biological properties. Proc Indian Natl Sci Acad. 2017;93(0):769-787.
57.
OlennikovDNKashchenkoNIVennosC. A new esculetin glycoside from Calendula officinalis (Asteraceae) and its bioactivity. Farmacia. 2017;65(5):698-702.
58.
OlennikovDNKashchenkoNI. Marigold metabolites: diversity and separation methods of calendula genus phytochemicals from 1891 to 2022. Molecules. 2022;27(23):8626.
59.
AdlerGKasprzykZ. Free sterols, steryl esters, glucosides, acylated glucosides and water-soluble complexes in Calendula officinalis. Phytochemistry. 1975;14(3):627-631.
60.
AlsoufiASMStaśkiewiczKMarkowskiM. Alterations in oleanolic acid and sterol content in marigold (Calendula officinalis) hairy root cultures in response to stimulation by selected phytohormones. Acta Physiol Plant. 2021;43(3):44.
61.
WojciechowskiZBocheńska-HryniewiczMKucharczakBKasprzykZ. Sterol and triterpene alcohol esters from Calendula officinalis. Phytochemistry. 1972;11(3):1165-1168.
62.
RogowskaAPączkowskiCSzakielA. Modulation of steroid and triterpenoid metabolism in Calendula officinalis plants and hairy root cultures exposed to cadmium stress. Int J Mol Sci. 2022;23(10):5640.
63.
JaniszowskaWMichalskiWKasprzykZ. Polyprenyl quinones and alpha-tocopherol in Calendula officinalis. Phytochemistry. 1976;15(1):125-127.
64.
BreemhaarHGBoumanA. Harvesting and cleaning Calendula officinalis, a new arable oilseed crop for industrial application. Ind Crops Prod. 1995;4(4):255-260.
65.
GazimZCRezendeCMFragaSRDias FilhoBPNakamuraCVCortezDAG. Analysis of the essential oils from Calendula officinalis growing in Brazil using three different extraction procedures. Rev Bras Ciencias Farm J Pharm Sci. 2008;44(3).
66.
RaalAOravANesterovitschJMaidlaK. Analysis of carotenoids, flavonoids and essential oil of Calendula officinalis cultivars growing in Estonia. Nat Prod Commun. 2016;11(8):1157-1160.
67.
KishimotoSMaokaTSumitomoKOhmiyaA. Analysis of carotenoid composition in petals of Calendula (Calendula officinalis L.). Biosci Biotechnol Biochem . 2005;69(11):2122-2128.
68.
LohaniAMishraAKVermaA. Cosmeceutical potential of geranium and calendula essential oil: determination of antioxidant activity and in vitro sun protection factor. J Cosmet Dermatol. 2019;18(2):550-557.
69.
GudzenkoAVKolіadychОPKurapovaТМ, et al.Study of volatile compounds of Сalendula officinalis L. flowers by the method of gas chromatography with MAS detection. Farm Zh.2023;(1):75-81.
70.
IslamRuKumarM. Extraction of total carotenoids from calendula officinalis and their effects on the oxidation stability of mustard oil. IOSR J Environ Sci Toxicol Food Technol. 2014;8(2):142-144.
71.
BakóEDeliJTóthG. HPLC study on the carotenoid composition of Calendula products. J Biochem Biophys Methods.2002;53(1-3):241-250.
72.
SausserdeRKampussK. Composition of Carotenoids in Calendula (Calendula officinalis L.) Flowers. 9th Balt Conf Food Sci Technol “Food Consum Well-Being.” 2014;(MAY).
73.
LinLTLiuLTChiangLCLinCC. In vitro anti-hepatoma activity of fifteen natural medicines from Canada. Phyther Res. 2002;16(5):440-444.
74.
AbasovaRLAslanovSMMamedovaMÉ. Amino acids of Calendula officinalis. Chem Nat Compd. 1994;30(5):641.
75.
VarljenJLiptákAWagnerH. Structural analysis of a rhamnoarabinogalactan and arabinogalactans with immuno-stimulating activity from Calendula officinalis. Phytochemistry. 1989;28(9):2379-2383.
76.
LimTK. Calendula officinalis. In: Edible medicinal and non-medicinal plants: volume 7, flowers [internet]. Springer Netherlands; 2014:213-244. Available from: https://doi.org/10.1007/978-94-007-7395-0_15
77.
BadamiRCMorrisLJ. The oxygenated fatty acid of calendula seed oil. J Am Oil Chem Soc. 1965;42(12):1119-1121.
78.
DulfFVPamfilDBaciuADPinteaA. Fatty acid composition of lipids in pot marigold (Calendula officinalis L.) seed genotypes. Chem Cent J. 2013;7(1):1-11.
79.
MullaicharamARAmareshNBalasubramaniamH. Phytochemistry and pleitropic pharmacolgoical properties of Calendula officinalis - A review. Res Rev J Pharmacogn Phytochem. 2014;2(4):1-10.
80.
KhalidKATeixeira da SilvaJA. Biology of Calendula officinalis Linn .: focus on pharmacology, biological activities and agronomic practices. Med Aromat Plant Sci Biotechnol. 2012;6(1):12-27.
81.
LoveckaPLipovJThumovaKMacurkovaA. Characterization of biologically active substances from Calendula officinalis. Curr Pharm Biotechnol. 2018;18(14):1167-1174.
82.
Mishra ArunKMishraAChattopadhayayP. Calendula officinalis: an important herb with valuable theraputic dimensions - An overview. J Global Pharma Technol. 2010;2(10):14-23.
83.
ChoNHShawJEKarurangaS, et al.IDF diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-281.
84.
KulkarniKVGhurghureSM. Indian gooseberry (Emblica officinalis): complete pharmacognosy review. Int J Chem Stud. 2018;2(2):5-11.
85.
ChakraborthyG. Antidiabetic and antihyperlipidaemic effect of hydro-alcoholic extract of Calencula officinalis. J Anal Bioanal Tech. 2010;2(1):61-65.
86.
AthaibanMA. Effect of Calendula officinalis extract against streptozotocin induced diabetes in male rats. Int J Pharm Phytopharm Res. 2018;8(6):22-28.
87.
KomakiAMoradkhaniSSalehiIAbdolmalekiS. Effect of Calendula officinalis hydroalcoholic extract on passive avoidance learning and memory in streptozotocin-induced diabetic rats. Anc Sci Life. 2015;34(3):156-161.
88.
EbrahimiEKheirollahAMansouriEBabaahmadi-RezaeiHMohammadzadehG. Effects of hydroalcoholic flower extract of marigold (Calendula officinalis) on the biochemical and histological parameters in STZ-induced diabetic rats. Jundishapur J Nat Pharm Prod. 2019;14(3).
89.
YoshikawaMMurakamiTKishiAKageuraTMatsudaH. Medicinal flowers. III. Marigold. (1): hypoglycemic, gastric emptying inhibitory, and gastroprotective principles and new oleanane-type triterpene oligoglycosides, calendasaponins A, B, C, and D, from Egyptian Calendula officinalis. Chem Pharm Bull. 2001;49(7):863-870.
90.
OlennikovDNKashchenkoNI. Componential profile and amylase inhibiting activity of phenolic compounds from Calendula officinalis L. leaves. Sci World J. 2014;2014.
91.
AhmedK. Effect of soil solarization and cattle manure on the growth, essential oil and chemical composition of Calendula officinalis L.J Appl Sci Res.2006;2(3):142-152.
92.
SabuMCKuttanR. Antioxidant activity of Indian herbal drugs in rats with aloxan-induced diabetes. Pharm Biol. 2003;41(7):500-505.
93.
HeroldACremerLCalugaruA, et al.Antioxidant properties of some hydroalcoholic plant extracts with antiinflammatory activity. Roum Arch Microbiol Immunol. 2003;62(3-4):217-227.
94.
PreethiKCKuttanGKuttanR. Antioxidant potential of an extract of Calendula officinalis flowers in vitro and in vivo. Pharm Biol. 2006;44(9):691-697.
95.
FatimaSSGovekarSUSatardekarKVBarveSSDhawalPP. In vitro analysis of ethanolic extract of flowers of Calendula officinalis for antioxidant, antimicrobial and uv-H2O2 induced DNA damage protection activity. J Pharmacogn Phytochem. 2018;7(5):2378-2383.
96.
BabaeeNMoslemiDKhalilpourM, et al.Antioxidant capacity of calendula officinalis flowers extract and prevention of radiation induced oropharyngeal mucositis in patients with head and neck cancers: a randomized controlled clinical study. DARU, J Pharm Sci. 2013;21(1):1-7.
97.
BalciunaitieneAPuzeryteVRadenkovsV, et al.Sustainable–green synthesis of silver nanoparticles using aqueous Hyssopus officinalis and Calendula officinalis extracts and their antioxidant and antibacterial activities. Molecules. 2022;27(22):1-14.
98.
DeuschleVCKNDeuschleRANPianaM, et al.Phytochemical evaluation and in vitro antioxidant and photo-protective capacity of Calendula officinalis L. leaves. Rev Bras Plantas Med. 2015;17(4):693-701.
99.
EscherGBBorgesLDCCSantosJS, et al.From the field to the pot: phytochemical and functional analyses of calendula officinalis l. flower for incorporation in an organic yogurt. Antioxidants. 2019;8(11).
100.
Garrido-SuárezBBGarridoGMenéndezAB, et al.Topical Calendula officinalis L. inhibits inflammatory pain through antioxidant, anti-inflammatory and peripheral opioid mechanisms. J Integr Med. 2023;21(1):34-46.
101.
SilvaDFerreiraMSSousa-LoboJMCruzMTAlmeidaIF. Anti-inflammatory activity of calendula officinalis l. Flower extract. Cosmetics. 2021;8(2):31.
102.
FarahpourMR. Antioxidant activity, antinociceptive and anti-inflammatory effects of pot marigold hydroalcoholic extract on experimental animals. Int J PharmTech Res. 2014;6(5):1640-1646.
103.
Prabhu VenkateshDGheenaSRamaniPRajeshkumarSRamalingamK. In vitro evaluation of antioxidant and anti-inflammatory potentials of herbal formulation containing marigold flower (Calendula officinalis L.) tea. Cureus. 2023;15(8).
104.
PreethiaKCKuttanbGKuttanR. Anti-inflammatory activity of flower extract of Calendula officinalis Linn. and its possible mechanism of action. Indian J Exp Biol. 2009;47(2):113-120.
105.
Della LoggiaR. The role of terpenoids in the anti-inflammatory activity of ca. Zeitschrift fur Phyther. 2000;21(3).
106.
Saify ZS , D of PC, Mushtaq N, Noor F, Arif M, Takween S, Ahmed SP. Analgesic and antimicrobial activity of the leaves extract of Calendula officinalis. Hamdard Medicus. 2000;43(1):34-37.
107.
HamadMNMohammedHJMerdawMA. Antibacterial activity of Calendula officinalis flowers in vitro. Ibn AL- Haitham J Pure Appl Sci. 2017;24(3).
108.
MabuzaM. Efficacy of Calendula officinalis as an antibacterial on in vitro pseudomonas aeruginosa. Eurasian J Med Oncol. 2018;2(2):55-60.
109.
ButnariuMCoradiniCZ. Evaluation of biologically active compounds from Calendula officinalis flowers using spectrophotometry. Chem Cent J. 2012;6(35):1-7.
110.
ChakraborthySG. Antimicrobial activity of the leaf extracts of Calendula officinalis (Linn.). J Herb Med Toxicol. 2008;2(2):65-66.
111.
SavalkarMBMulaniYSGaikwadSS. To study antibacterial activity of Calendula officinalis. Int J Pharm Pharm Res. 2019;15.
112.
FederalURegionalUNaturaisPMolecularBLeF. Antibacterial and antioxidant activities of water extract of Calendula officinalis flowers. 2012;64(2):459–64.
113.
ZakiAAshourAMiraA, et al.Biological activities of oleanolic acid derivatives from Calendula officinalis seeds. Phyther Res. 2016;30(5):835-841.
114.
GounECunninghamGChuDNguyenCMilesD. Antibacterial and antifungal activity of Indonesian ethnomedical plants. Fitoterapia. 2003;74(6):592-596.
115.
AlsarafKMohamedMAl-shammariMAAbbasI. Broad-spectrum cytotoxic effect of Calendula officinalis L against breast cancer cells. Indian J Forensic Med Toxicol. 2020;14(1):803-809.
116.
BehbahaniM. Evaluation of in vitro anticancer activity of Ocimum basilicum, Alhagi maurorum, Calendula officinalis and their parasite Cuscuta campestris. PLoS One. 2014;9(12).
117.
CruceriuDBalacescuORakosyE. Calendula officinalis: potential roles in cancer treatment and palliative care. Integr Cancer Ther.2018;17(4):1068-1078.
118.
RayDMukherjeeSFalchiMBertelliACarlo BragaPK. DasD. Amelioration of myocardial ischemic reperfusion injury with Calendula officinalis. Curr Pharm Biotechnol. 2010;11(8):849-854.
119.
BashirSJanbazKHJabeenQGilaniAH. Studies on spasmogenic and spasmolytic sctivities of Calendula officinalis flowers. Phyther Res. 2006;20(10):906-910.
120.
ChandraPKishoreKGhoshAK. Evaluation of antacid capacity and antiulcer activity of Calendula officinalis L. in experimental rats. Orient Pharm Exp Med. 2015;15(4):277-285.
YadavAKMishraPKRaoCVSinghVDivisionPMargRP. Investigation of Calendula officinalis whole plant as a gastroprotective and antioxidant in peptic ulcer. Br J Med Health Research . 2016;3(7):67-76.
123.
BakrimSBenkhairaNBouraisI, et al.Health benefits and pharmacological properties of stigmasterol. Antioxidants. 2022;11(10):1912.
124.
AzemiAKNordinMLHambaliKANoralidinNAMokhtarSSRasoolAHG. Phytochemical contents and pharmacological potential of Parkia speciosa hassk for diabetic vasculopathy: a review. Antioxidants. 2022;11(2):431.
125.
YatsunoAIBelovaLFLipkinaGS. Pharmacology of calenduloside B. A new terpene glycoside obtained from the roots of Calendula officinalis. Russ Pharmacol Toxicol. 1978;41(5):1149-1153.
126.
DasPMajumderRMandalMBasakP. In-silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis. J Biomol Struct Dyn. 2021;39(16):6265-6280.
127.
PandaSKLuytenW. Antiparasitic activity in Asteraceae with special attention to ethnobotanical use by the tribes of Odisha, India. Parasite. 2018;25(10).
128.
GongGGuanYYZhangZL, et al.Isorhamnetin: a review of pharmacological effects. Biomed Pharmacotherapy. 2020;128(110301):1-15.
129.
SheikhTAGanieSYReshiMS. Phytochemistry, pharmacological properties and medicinal uses of Apium leptophyllum: a review. Pharmacogn Rev. 2023;17(33):135-143.
130.
BouyahyaAMechchateHBenaliT, et al.Health benefits and pharmacological properties of carvone. Biomolecules. 2021;11(12):1803.
131.
SilvaEJRGonçalvesESAguiarF, et al.Toxicological studies on hydroalcohol extract of Calendula officinalis L. Phyther Res. 2007;21(4):332-336.
132.
ElzorbaH. Some pharmacological & toxicological activities of Calendula officinalis Linn. Flower 70% ethanolic extract. Anim Vet Sci. 2016;4(2):26.
133.
LagartoABuenoVGuerraIValdésOVegaYTorresL. Acute and subchronic oral toxicities of Calendula officinalis extract in Wistar rats. Exp Toxicol Pathol. 2011;63(4):387-391.
134.
MishraAKMishraA ChattopadhyayP. Screening of acute and sub-chronic dermal toxicity of Calendula officinalis L. essential oil. Regul Toxicol Pharmacol. 2018;98:184-189.
SchneiderC. Traumeel – an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med. 2011;4:225-234.
138.
SarrellEMCohenHAKahanE. Naturopathic treatment for ear pain in children. Pediatrics. 2003;111(5):574-579.
139.
ChandorkarNTambeSAminPMadankarC. A systematic and comprehensive review on current understanding of the pharmacological actions, molecular mechanisms, and clinical implications of the genus Eucalyptus. Phytomedicine Plus. 2021;1(4):100089.